Auro Laboratories Analysis (March 2026) | Price Development & Price Target

Auro Laboratories

BSE:530233

Rp 265,00

Rp-7,80 (-2,86%)

265,00 Rp

Rp-7,80 (-2,86%)

End-of-day quote: 03/30/2026

Auro Laboratories Stock Value

The analyst rating for BSE:530233 is currently sf_Data Unavailable.

Auro Laboratories Company Info

EPS Growth 5Y

0,00%

Market Cap

Rp1,70 B

Long-Term Debt

Rp0,31 B

Annual earnings

05/23/2026 (E)

Dividend

Rp0,00

Dividend Yield

0,00%

Founded

1989

Industry

Materials

Country

India

Website

Auro Laboratories

ISIN Number

INE292C01011

Website

http://www.aurolabs.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Auro Laboratories’s Price Target has risen from Rp0,00 to Rp265,00 - a 100,00% increase.

Top growth stocks in the materials sector (5Y.)

What does Auro Laboratories do?

Auro Laboratories Limited operates primarily in the pharmaceutical sector, focusing on the manufacture and supply of bulk drugs. The company produces a variety of active pharmaceutical ingredients (APIs) along with formulations that cater to both domestic and international markets. Business Segments The company's operations can primarily be divided into two essential segments: API manufacturing and finished formulations. API Manufacturing This segment focuses on the production of active phar...

Business Segments

The company's operations can primarily be divided into two essential segments: API manufacturing and finished formulations.

API Manufacturing

This segment focuses on the production of active pharmaceutical ingredients, or APIs, which are crucial components in the formulation of medications. The company produces a diverse range of APIs including anti-infectives, anti-cancers, and other specialty drugs.

Finished Formulations

This segment also engages in the development and manufacturing of finished pharmaceutical formulations. The formulations produced range from tablets to injectables.

Business Strategy

The company employs a comprehensive business strategy aimed at achieving sustained growth while ensuring operational efficiency. The company prioritizes research and development as a cornerstone of its strategic approach, investing significantly in innovative processes and product development. By focusing on R&D, the company seeks to enhance its product offerings, improving efficacy and expanding into new therapeutic areas.

Another essential aspect of the company’s strategy involves strategic partnerships and collaborations. The company works in tandem with other pharmaceutical companies, regulatory bodies, and research institutions to facilitate knowledge sharing and expand its market reach. This collaborative approach enables the company to stay at the forefront of pharmaceutical advancements.

The company is also heavily invested in marketing and customer relations, seeking to build long-lasting relationships with both customers and healthcare professionals. The emphasis on customer service aids in client retention and fosters brand loyalty in competitive markets. Through targeted marketing campaigns and a strong online presence, the company enhances brand visibility and engages effectively with its target audience.

Products and Services

The company offers a diverse array of products and services tailored to meet the needs of the global pharmaceutical market. Key offerings include:

Active Pharmaceutical Ingredients (APIs): The company produces a wide range of APIs used in various pharmaceutical formulations. The APIs are suitable for diverse therapeutic applications such as anti-infectives, cardiovascular drugs, and more.

Finished Dosage Forms: The company also focuses on the manufacture of finished dosage forms including tablets, capsules, and injectables.

Contract Manufacturing Services: The company offers contract manufacturing services.

Research and Development Services: The company offers dynamic market needs.

Geographical Markets Served

The company serves a diverse set of geographical markets, extending its reach globally. The company supplies its products across various regions, including North America, Europe, Asia, and emerging markets.

Customers

The company caters to a broad spectrum of customers, including various pharmaceutical companies, healthcare providers, and distributors. The customer base encompasses both local and international entities. The company serves numerous clients across different therapeutic categories, including anti-infectives, oncology, and cardiovascular treatments.

Sales and Marketing

The company employs a multifaceted sales and marketing strategy to promote and distribute its products. The company utilizes both direct sales channels and partnerships with distributors to ensure efficient market reach. Marketing efforts include participation in international trade shows, scientific conferences, and engagement in online promotions to increase brand visibility.

The company relies heavily on digital marketing strategies, using social media and online advertising to connect with customers and stakeholders. The company recognizes the importance of building relationships with healthcare professionals to foster trust and awareness of its products.

History

Auro Laboratories Limited was incorporated in 1989.

New support ticket

Explore

Auro Laboratories Stock Value

Auro Laboratories Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Auro Laboratories do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Auro Laboratories Stock Value

Auro Laboratories Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Auro Laboratories do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.